← Back to Search

Pulmonary Exerciser

Lung Master Device for Lung Conditions

N/A
Waitlist Available
Led By Farahnaz Fallah Tafti, PhD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Fall within the age ranges: 19-35 and above 65 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and after one month of device use
Awards & highlights

Summary

This trial is testing a device called The Lung Master to see if it can help people breathe better by increasing the amount of air their lungs can hold. The device is not yet approved by the FDA.

Who is the study for?
This trial is for individuals with breathing difficulties due to conditions like Asthma or COPD. Participants should be able to attend two study visits one month apart and use the Lung Master device daily, recording their usage in a diary.
What is being tested?
The trial is testing the Lung Master, an investigational device designed to increase lung capacity. It involves initial and follow-up spirometry tests one month apart to measure changes in lung volume after daily use of the device.
What are the potential side effects?
Since this trial involves a non-invasive pulmonary exerciser, side effects may include discomfort from regular use or fatigue during exercises. Specific side effects will depend on individual tolerance to respiratory training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am either between 19-35 years old or older than 65.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and after one month of device use
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and after one month of device use for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Inspiratory Capacity
Tidal Volume

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lung Function in Young and Older AdultsExperimental Treatment1 Intervention
Lung functions will be assess for two groups: young and older adults. The age range of 19 to 35 is categorized as young adulthood. This age range was selected because the lungs mature around 19-25 years old. The age range above 65 is designated as late adulthood, where lung function gradually declines.

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
554 Previous Clinical Trials
1,145,378 Total Patients Enrolled
Farahnaz Fallah Tafti, PhDPrincipal InvestigatorUniversity of Nebraska
~13 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top